INTRODUCTION
============

The radial nerve is responsible for innervating the extensor compartments of the arm \[[@b1-arm-2018-42-4-601]\]. After leaving the axilla, the radial nerve travels closely around the posterolateral aspect of the humeral shaft. After distributing muscular branches to the triceps brachii and the anconeus muscles, the radial nerve wraps around the humerus in the spiral groove (SG). Because of its close proximity to the humerus and its stability when it penetrates the lateral intermuscular septum, the radial nerve becomes susceptible to compression \[[@b2-arm-2018-42-4-601]\]. The radial nerve is commonly injured by trauma, usually only secondary to humeral fracture, and not as commonly by external nerve compression ('Saturday night palsy') \[[@b3-arm-2018-42-4-601]\], related to its previously mentioned anatomical susceptibility and, rarely, by strenuous muscular effort or infarction from vasculitis \[[@b4-arm-2018-42-4-601]\].

The diagnosis of radial neuropathy is based on clinical history, physical examination, and electrodiagnostic study. Among these, electrodiagnosis can be used not only to evaluate the functional state of the nerve, but also to locate lesions more accurately. It is possible to demonstrate conduction blocks or decrease of conduction velocity across the lesions, using nerve conduction studies \[[@b3-arm-2018-42-4-601]\] or abnormal needle electromyographic findings of muscles innervated from the radial nerve \[[@b4-arm-2018-42-4-601],[@b5-arm-2018-42-4-601]\]. To date, electrodiagnostic studies have played a key role in the diagnosis of neuropathy \[[@b6-arm-2018-42-4-601]-[@b8-arm-2018-42-4-601]\].

Owing to technical developments in the field of imaging techniques, ultrasonography and magnetic resonance imaging can now be used as additional tests to diagnose difficult neuropathy cases with excellent resolution and results. These techniques have unique advantages of providing the anatomical location of neuropathy and the visual information regarding etiology \[[@b9-arm-2018-42-4-601]\]. In particular, ultrasonography has the benefits of cost-effectiveness, real-time imaging, portability, non-invasiveness, and are compatible with implanted metal devices and are radiation-free. Consequently, they have become a widespread imaging method to evaluate the peripheral nerves \[[@b2-arm-2018-42-4-601],[@b10-arm-2018-42-4-601]\]. Ultrasonography reveals nerve swelling and can quantify it by measurement of nerve cross-sectional area (CSA). Although measuring CSA on a transverse scan is the most commonly used examination to diagnose entrapment neuropathies \[[@b9-arm-2018-42-4-601]-[@b14-arm-2018-42-4-601]\], few studies have investigated cut-off values for sonographic diagnosis of radial neuropathy at the SG.

The goal of the present study is to evaluate the diagnostic value of ultrasonographic measurements, and the efficacy of ultrasonography in the diagnosis of radial neuropathy at the SG. The second goal is to assess the correlation between CSA and electrophysiological severity.

MATERIALS AND METHODS
=====================

The study protocol was approved by the Institutional Review Board of the Yeouido St. Mary's Hospital (No. SC14RISI0141). We retrospectively assessed medical records detailing the clinical and electrodiagnostic evaluation of 17 patients diagnosed with radial neuropathy at the SG and recruited 30 controls without a history of the relevant disease. All individuals in the patient and control groups were greater than 18 years of age. Patients were excluded if they had any trauma or upper arm surgery tha t was not related to radial neuropathy. Additionally, patients with any other neurological disease(s), such as central nervous system disease, cervical radiculopathy, brachial plexopathy, polyneuropathy, or that involving only the superficial radial nerve were excluded.

Electrodiagnosis was based on guidelines \[[@b4-arm-2018-42-4-601],[@b5-arm-2018-42-4-601]\] as follows: abnormal radial sensory nerve action potential (if axonal); low radial compound muscle action potential (CMAP) (if axonal); conduction block at SG (if demyelinating); and needle electromyography (EMG) abnormalities in the radial nerve innervated muscle (except the anconeus and triceps). Any drop in CMAP amplitude ≥50% between the proximal and distal site was defined as a conduction block. CMAP amplitude comparisons were made with the contralateral side, and reduction ≥50% in amplitude was defined as axonal loss \[[@b3-arm-2018-42-4-601]\]. For statistical analysis, a scale designed by Mondelli et al. \[[@b15-arm-2018-42-4-601]\] was used for electrophysiological assessment of the severity of radial neuropathy at the SG. This score was based on the following electrophysiological parameters: (1) sensory conduction velocity (SCV) and amplitude of sensory nerve action potential (SNAP); (2) percentage decrease in CMAP amplitude across the nerve lesion; (3) motor conduction velocity (MCV) across the nerve lesion; and (4) needle EMG of radial-innervated muscles (except the anconeus and triceps) ([Table 1](#t1-arm-2018-42-4-601){ref-type="table"}). The sampled muscles for needle EMG differed depending on the physician that performed the examination; there were 2--6 of the radialinnervated muscles. The brachioradialis was evaluated in all cases. The next most-sampled muscles were the extensor digitorum communis, followed by the extensor carpi radialis, and the extensor indicis proprius. The EMG score is the mean of EMG scores of radial-innervated muscles. The total electrophysiological score of radial neuropathy at the SG was the sum of all scores in each domain.

All ultrasonography examinations were performed bilaterally by a physiatrist using a 7--12 MHz linear array probe (Voluson E; GE Healthcare, Waukesha, WI, USA) that was blinded to the clinical and electrodiagnostic results of each subject. The ultrasonography examinations were performed immediately after the electrodiagnostic studies. All patients and controls were examined in the supine position with the forearm pronated, and the elbow moderately flexed during evaluation. The probe was carefully positioned as perpendicular as possible to the nerve, and applied with minimal pressure to avoid compression of the nerve. The radial nerve was scanned along its course from the proximal area to the SG to the antecubital fossa in the distal humerus; the largest CSA nearest the proximal area of the SG was measured at the inner border of hyperechoic epineurium of the nerve using a continuous tracing technique in both groups ([Fig. 1](#f1-arm-2018-42-4-601){ref-type="fig"}). CSAs were measured on transverse images, and the mean values were calculated from three measurements. All captured images were re-examined by a qualified physiatrist. The following values were calculated in addition to CSA: differences in CSA at the SG between symptomatic and asymptomatic sides (ΔSx--Asx); ratio of CSA at the SG between symptomatic and asymptomatic sides (Sx/Asx). In the control group, differences and ratio of CSA at the SG were obtained between the right and left sides.

Statistical analyses
--------------------

Statistical analysis was performed using SPSS version 21.0 (IBM, Armonk, NY, USA) for Windows (Microsoft Corporation, Redmond, WA, USA). The chi-square, t-test, and Mann-Whitney test were used to compare variables in the patient and control groups. The normality of the data was verified using the Shapiro-Wilk test. The Mann-Whitney test was used to analyze differences in CSA measurements between the two groups; p\<0.05 was considered statistically significant in all tests. Receiver operating characteristic (ROC) curve analysis was performed to determine optimal cut-off points of the measurements using ultrasonography in diagnosing radial neuropathy at the SG. Spearman correlation coefficient was used to examine the relationships between the values of CSA and electrophysiological severity scale scores.

RESULTS
=======

In this study, all 17 patients and 30 healthy controls underwent clinical examination, and electrodiagnostic and ultrasonographic evaluations of the radial nerve. No significant differences in baseline characteristics between the patients and controls were observed (p\>0.05) ([Table 2](#t2-arm-2018-42-4-601){ref-type="table"}). The duration between the onset of symptom(s) and the time of clinic visit ranged from one week to 43 months (median, 3 months).

Humerus fractures (n=10) were the most common cause of radial neuropathies, followed by external compressions (n=7).

The electrophysiological severity scale scores are reported in [Table 3](#t3-arm-2018-42-4-601){ref-type="table"}. Except for the EMG score, there was a statistical difference in electrophysiological severity scale between each patient group divided according to etiology.

[Table 4](#t4-arm-2018-42-4-601){ref-type="table"} summarizes CSA values at the SG, the ΔSx--Asx, and Sx/Asx between the patient and control groups. In the patient group, the mean CSA of the radial nerve at the SG was 7.01±2.97 mm^2^, which was significantly larger than the corresponding area in the control group (p\<0.01). In addition, the ΔSx--Asx and Sx/Asx were larger than that of the control group (p\<0.001 for all).

ROC curve analysis was used to assess cut-off points for ultrasonographic measurements, and its diagnostic sensitivity and specificity. The cut-off values for diagnosis of radial neuropathy at the SG with relatively high sensitivity and specificity were 5.75 mm^2^ (sensitivity 52.9%, specificity 90%) for radial nerve CSA at the SG, 1.75 mm^2^ for ΔSx--Asx (sensitivity 58.8%, specificity 100%), and 1.22 for Sx/Asx (sensitivity 70.6%, specificity 93.3%) ([Table 5](#t5-arm-2018-42-4-601){ref-type="table"}).

No significant correlations with radial nerve CSA at the SG and the electrophysiological severity scale were observed (p\>0.05) in all patients and subgroups divided according to etiology. Additionally, there were no significant differences in radial nerve CSA at the SG between the humerus fracture and external compression group (p\>0.05).

DISCUSSION
==========

The aim of this study was to assess the diagnostic efficacy of ultrasonography in addition to electrodiagnostic study by measuring the CSA of the radial nerve at the SG. Ultrasonography appeared to be an adequately sensitive and specific test in revealing radial nerve swelling at the SG. At the SG, patients exhibited a significantly larger mean radial nerve CSA than healthy controls, which was also reported in a previous study \[[@b3-arm-2018-42-4-601]\]. We found several cut-off values that were statistically significant in diagnosing radial neuropathy at the SG. This was the first study to research and propose diagnostic cut-off values for ultrasonography in radial neuropathy at the SG.

There have been many studies supporting the usefulness of ultrasonography as an adjunctive diagnostic tool to electrodiagnostic studies for peripheral neuropathy. However, most of these studies investigated the median and ulnar nerves \[[@b9-arm-2018-42-4-601],[@b11-arm-2018-42-4-601],[@b12-arm-2018-42-4-601],[@b16-arm-2018-42-4-601],[@b17-arm-2018-42-4-601]\], and seldom used ultrasonography to diagnose radial neuropathy. That is, except for several studies describing trauma or cyst(s) that examined the causes of radial neuropathy \[[@b7-arm-2018-42-4-601],[@b18-arm-2018-42-4-601]-[@b20-arm-2018-42-4-601]\].

For the radial nerve site we evaluated, normal reference values have been previously reported \[[@b10-arm-2018-42-4-601],[@b21-arm-2018-42-4-601]-[@b23-arm-2018-42-4-601]\]. Although some of these studies used the same nerve tracing method, there were few discrepancies in the suggested normal values. Potential explanations for these differences are that the participants differed in ethnicity, gender, age, height, and weight distribution. The different frequency of transducers used or measurement error may be other possible causes. To minimize these differences, future studies should compare the results of this study with investigations that used similar conditions. In one previous study \[[@b21-arm-2018-42-4-601]\], the normal reference value for the CSA of the radial nerve was 4.61±0.88 mm^2^. Based on this normal value, despite the relatively low sensitivity, the cut-off value of 5.75 mm^2^ (sensitivity 52.9%, specificity 90%) determined in our study appears to be appropriate to diagnose radial neuropathy at the SG ([Table 5](#t5-arm-2018-42-4-601){ref-type="table"}). For higher sensitivity, we propose 4.95 mm^2^ (sensitivity 82.4%, specificity 60%) as an alternative cut-off value. This value overlaps with the aforementioned normal reference; therefore, it is likely to include many false positives. To overcome this weakness, it would be helpful to verify additional ΔSx--Asx and Sx/Asx values for diagnoses in patients with the suspected disease.

As mentioned earlier, in many other studies investigating CSA reference values for the sonography of the peripheral nerves, the CSA appeared to be correlated with gender \[[@b24-arm-2018-42-4-601]\], height \[[@b21-arm-2018-42-4-601]\], weight, body mass index, and age \[[@b23-arm-2018-42-4-601],[@b25-arm-2018-42-4-601]\]. Therefore, using the contralateral side as an internal control \[[@b26-arm-2018-42-4-601],[@b27-arm-2018-42-4-601]\] to verify ΔSx--Asx and Sx/Asx, we can reduce these biases. The mean value of ΔSx--Asx was 2.54±2.45 mm^2^, and 1.75 mm^2^ was the cut-off value of ΔSx--Asx in radial neuropathy at the SG, with a sensitivity of 58.8% and specificity of 100%. The mean value of the Sx/Asx ratio was 1.62±0.66, and the cut-off value for radial neuropathy at the SG was 1.22 (sensitivity of 70.6%, specificity of 93.3%). Although ΔSx--Asx and Sx/Asx were useful, they are not applicable to bilateral or diffused lesions \[[@b26-arm-2018-42-4-601],[@b28-arm-2018-42-4-601]\] For these cases, electrodiagnostic study is predicted to play a better role.

In this study, the only characteristic that had a statistically significantly larger CSA was at the SG. The CSA values in the antecubital fossa, which we did not examine in this study, may also be larger in some cases. In an ultrasonography study investigating ulnar neuropathy at the elbow \[[@b29-arm-2018-42-4-601]\], the CSA was significantly larger, not only at the medial epicondyle, but also distally, farthest from the medial epicondyle, and even at the wrist. In another study \[[@b30-arm-2018-42-4-601]\], significantly larger CSAs were also noted 5 cm proximal from and distal to the medial epicondyle. Collectively, these findings could explain that the pattern of edema that occurs after nerve injury may differ depending on the site, degree, and mechanism of injury. Therefore, if the maximal swelling point was found in the non-SG portion, additional ΔSx--Asx or Sx/Asx inquiry can be used to supplement the diagnosis.

In addition to determining the diagnostic value of ultrasonographic measurements in radial neuropathy at the SG, we performed a correlation analysis of CSAs and electrophysiological severity scale scores and found no significant correlation. Although not related to radial neuropathy, the relationship between ultrasonographic measurements and electrodiagnostic studies has been reported in several previous studies \[[@b16-arm-2018-42-4-601],[@b29-arm-2018-42-4-601],[@b31-arm-2018-42-4-601]-[@b33-arm-2018-42-4-601]\], but there have been conflicting results. This could be explained by several factors such as variability in nerve pathologies related to causes, relationship(s) with peripheral tissue, and the concept that ultrasound primarily assesses anatomy and electrodiagnostic studies primarily assess nerve function \[[@b16-arm-2018-42-4-601]\].

There were some limitations to this study. First, because of the low incidence of radial neuropathy compared with other nerve lesions, this study had a relatively small number of subjects; therefore, it may be difficult to generalize the results. Second, there was variability in the duration between the onset of symptoms and the time to the clinic visit. This could have altered the degree of nerve swelling and possibly influenced the outcomes. Third, the cut-off value of radial CSA at the SG in the present study had a relatively lower sensitivity than that reported in other studies investigating other neuropathies. This may be because we only recruited patients with electrophysiologically confirmed radial neuropathy at the SG, and used fixed points of measurement of CSA at the SG to achieve this high level of standardization in our results. Fourth, intra-rater and inter-rater reliability were not evaluated. However, for intra-rater agreement, we calculated the mean CSA from three measurements. For inter-rater agreement, an experienced and qualified physiatrist reviewed the ultrasonographic images. Despite these shortcomings, this investigation is the first original study to propose diagnostic ultrasonography cutoff values for radial neuropathy at the SG.

In conclusion, ultrasonography is a useful additional tool to electrodiagnosis for diagnosing radial neuropathy at the SG. Our study may be helpful for the diagnosis of radial neuropathy at the SG in clinical practice. Further studies are required to confirm our findings on a larger scale and in different ethnic groups.
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![Ultrasonographic images of the radial nerve at a site just proximal to the spiral groove. The radial nerve is shown inside the dotted line. (A) Radial nerve in normal controls and (B) radial nerve in patients. H, humerus. T, triceps.](arm-2018-42-4-601f1){#f1-arm-2018-42-4-601}

###### 

Electrophysiological severity scale of radial neuropathy at the spiral groove^[a)](#tfn1-arm-2018-42-4-601){ref-type="table-fn"}^

  Score   SCV and amplitude of SNAP                                     Amplitude of CMAP^[b)](#tfn2-arm-2018-42-4-601){ref-type="table-fn"}^   MCV                                               EMG^[c)](#tfn3-arm-2018-42-4-601){ref-type="table-fn"}^
  ------- ------------------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------------- --------------------------------------------------------------------------------------------
  0       Normal                                                        Normal (\<20%)                                                          Normal                                            Normal
  1       Decreased amplitude of SNAP with respect to unaffected side   \>20%, \<50%                                                            Decreased by \<25% with respect to lower limits   Reduced interferential pattern at full effort with or without denervation activity at rest
  2       Absolutely decreased amplitude of SNAP, normal SCV            \>50%, \<100%                                                           Decreased by \>25% with respect to lower limits   Discrete interferential pattern at full effort
  3       Decreased SCV and amplitude of SNAP                           Absence of CMAP                                                         Absence of CMAP                                   Single interferential pattern at full effort
  4       Absence of SNAP                                                                                                                                                                         No MUAP

SCV, sensory conduction velocity; SNAP, sensory nerve action potential; CMAP, compound muscle action potential; MCV, motor conduction velocity; EMG, electromyography; MUAP, motor unit action potential.

Scale from Mondelli et al. \[[@b15-arm-2018-42-4-601]\].

Decrease in percentage of CMAP amplitude, stimulating above and below site of nerve injury.

The EMG score is the mean of EMG scores of affected radial-innervated muscles (except, the anconeus and triceps).

###### 

Comparison of demographic characteristics of patients and controls

  Characteristic              Controls (n=30)   Patients (n=17)   p-value
  --------------------------- ----------------- ----------------- ---------
  Sex                                                             0.29
   Male                       15                12                
   Female                     15                5                 
  Age (yr)                    45.23±13.58       43.24±16.49       0.67
  Duration of symptoms (mo)   \-                3 (0.86-17)       
  Height (cm)                 165.23±7.24       171.00±9.68       0.07
  Weight (kg)                 63.62±10.84       69.62±11.18       0.13
  BMI (kg/m^2^)               23.24±3.24        23.72±2.59        0.61
  Side                                                            
   Right                      30                10                
   Left                       0                 7                 

Values are presented as mean±standard deviation or median (1st quartile--3rd quartile).

BMI, body mass index.

###### 

Electrophysiological severity scale scores in patients with radial neuropathy at the spiral groove

  Parameter                   Humerus fracture (n=10)   External compression (n=7)                                        Total
  --------------------------- ------------------------- ----------------------------------------------------------------- -----------
  SCV and amplitude of SNAP   2.50±1.08                 0^[\*\*](#tfn4-arm-2018-42-4-601){ref-type="table-fn"}^           1.47±1.50
  Amplitude of CMAP           2.70±0.48                 1.43±0.53^[\*\*](#tfn4-arm-2018-42-4-601){ref-type="table-fn"}^   2.18±0.81
  MCV                         2.50±0.97                 0.14±0.38^[\*\*](#tfn4-arm-2018-42-4-601){ref-type="table-fn"}^   1.53±1.42
  EMG                         2.29±1.27                 1.60±1.00                                                         2.00±1.18
  Total                       9.99±2.90                 3.17±1.18^[\*\*](#tfn4-arm-2018-42-4-601){ref-type="table-fn"}^   7.18±4.15

Values are presented as mean±standard deviation.

SCV, sensory conduction velocity; SNAP, sensory nerve action potential; CMAP, compound muscle action potential; MCV, motor conduction velocity; EMG, electromyography.

p\<0.01, differences between each group separated according to etiology.

###### 

Ultrasonographic measurements of the radial nerve of the subjects

  Characteristic               Controls    Patients    p-value
  ---------------------------- ----------- ----------- ---------------------------------------------------------------
  CSA at the SG (mm^2^)        4.65±0.82   7.01±2.97   0.005^[\*\*](#tfn5-arm-2018-42-4-601){ref-type="table-fn"}^
  ΔSx--Asx at the SG (mm^2^)   0.07±0.58   2.54±2.45   \<0.001^[\*\*](#tfn5-arm-2018-42-4-601){ref-type="table-fn"}^
  Sx/Asx at the SG             1.02±0.14   1.62±0.66   \<0.001^[\*\*](#tfn5-arm-2018-42-4-601){ref-type="table-fn"}^

Values are presented as mean±standard deviation.

CSA, cross-sectional area; SG, spiral groove; ΔSx--Asx, differences of CSA at the SG between symptomatic and asymptomatic sides; Sx/Asx, ratio of CSA at the SG between symptomatic and asymptomatic sides.

p\<0.01.

###### 

Cut-off values for diagnosing radial neuropathy at the spiral groove, with sensitivity and specificity

  Parameter                    Cut-off   Sensitivity (%)   Specificity (%)   AUC
  ---------------------------- --------- ----------------- ----------------- -------
  CSA at the SG (mm^2^)        5.75      52.9              90.0              0.748
  ΔSx--Asx at the SG (mm^2^)   1.75      58.8              100               0.858
  Sx/Asx at the SG             1.22      70.6              93.3              0.854

CSA, cross-sectional area; SG, spiral groove, ΔSx--Asx, differences of CSA at the SG between symptomatic and asymptomatic sides; Sx/Asx, ratio of CSA at the SG between symptomatic and asymptomatic sides; AUC, area under the curve.
